Skip to main content

Genix Pharmaceuticals: Top 25 Performing Stocks Year-to-Date on TSX Venture Exchange (GENX)

AI-generated - The Globe and Mail - Wed Jul 31, 2024

Genix Pharmaceuticals Corp is among the group of top performing stocks year-to-date on the TSX Venture Exchange. This means each stock on this list has seen its share price grow at a faster rate than the rest of the market so far this year.

This report is generated monthly. It highlights the 25 companies with the greatest percentage increase in share price year-to-date. Stocks in this category are generally held for appreciation or speculation.

Companies experiencing dramatic increases in share price can do so for a variety of reasons – including bullish changes in sector outlook, potential corporate takeover, or the company has restructured and earnings are better than expected.

SymbolNameTotal ReturnPeriod
ADYAdyton Resources Corp2200YTD
ESSEsstra Industries Inc900YTD
BMMBlack Mammoth Metals Corp864.705882YTD
RARETactical Resources Corp800YTD
NCINTG Clarity Networks Inc540YTD
ECOMEmerge Commerce Ltd450YTD
MILLMillbank Mining Corp420YTD
ARICAwale Resources Ltd418.518519YTD
PBXPowerBand Solutions Inc400YTD
BNZBonanza Mining Corp366.666667YTD
GENXGenix Pharmaceuticals Corp350YTD
GHLGoldhills Holding Ltd350YTD
GQGreat Quest Gold Ltd350YTD
SPRQSPARQ Systems Inc344.444444YTD
BFMBedford Metals Corp342.018835YTD
SFRSandfire Resources America Inc305.882353YTD
SEISintana Energy Inc303.333333YTD
ARDArmada Data Corp300YTD
PPXPPX Mining Corp300YTD
KRYKoryx Copper Inc290YTD

All data provided as of August 01, 2024.

More about Genix Pharmaceuticals Corp

Genix Pharmaceuticals Corp is a Canadian life sciences company. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals.

Genix Pharmaceuticals Corp is listed under GENX on the TSX Venture Exchange.

Artificial intelligence at Report on Business

Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.

This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.